Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,394,925
-$4,351,316 QoQ
Shares Held
363,872
-52.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#88
of 639 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $64,099,635 across 21 Drug Manufacturers - Specialty & Generic names. HLN ranks #8 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
|
319,625 | $13,574,473 | |
| 2 | ALKS |
Alkermes plc.
|
195,174 | $10,227,117 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
710,816 | $7,108,160 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
130,982 | $5,374,191 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
305,991 | $5,296,704 | |
| 6 | ZTS |
Zoetis Inc.
|
63,752 | $4,581,218 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
41,217 | $3,411,943 | |
| 8 | HLN |
Haleon plc
This page
|
363,872 | $3,394,925 |
All Filings in HLN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,394,925 | 363,872 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $7,746,241 | 766,196 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,332,213 | 482,967 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,041,033 | 196,821 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,592,704 | 446,327 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,313,200 | 137,652 | Shares | Sole | 2025-02-14 | |
| 2023-03-31 | $157,102 | 19,300 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||